Société de l’arthrite du Canada / Arthritis Society Canada
Enregistrement :
6
de
10
(2022-10-17
à
2023-11-16)
Politique ou Programme
Advocacy for development of a coordinated national strategy for musculoskeletal conditions that will align strategic directions, exchange best practices and integration of prevention, detection and management systems across Canada
Communication with federal government officials with respect to promoting research and federal-provincial coordination in best practices for arthritis patient care
Engagement with the Advisory Committee on the Implementation of National Pharmacare and its Secretariat on issues related to medicines for chronic diseases, such as arthritis
Health Canada's office of pharmaceutical management strategies, specifically with respect to Health Canada's role in supporting and directing federal, national and inter-jurisdictional pharmaceutical policy
Promoting workplace productivity and wellness initiatives for musculoskeletal health
Politique ou Programme, Règlement
Excise Tax Act, specifically with respect to the application of sales tax on medical cannabis
Politique ou Programme, Subvention, Contribution ou autre avantage financier
Funding from the federal government for research related to arthritis and to support patient oriented research
Proposition législative, Projet de loi ou résolution
Discussions with government officials with respect to the legalization and regulation of marijuana as it relates to medical cannabis policy
Proposition législative, Projet de loi ou résolution, Règlement
Employment Insurance Act, specifically with respect to episodic disabilities and/or caregivers
Food and Drugs Act and Regulations, specifically with respect to the special access programme for patients living with arthritis
Règlement
Canada Pension Plan, specifically the term "severe and prolonged" in s. 42 to broaden its application to more Canadians.
Patented Medicine Prices Review Board, specifically with respect to the regulation of pricing of patented drug products